DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Dapivirine is an investigational drug.
There have been 39 clinical trials for Dapivirine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Immunologic Deficiency Syndromes. The leading clinical trial sponsors are International Partnership for Microbicides, Inc., National Institute of Allergy and Infectious Diseases (NIAID), and National Institutes of Health (NIH).
There are twenty-nine US patents protecting this investigational drug and six hundred and ninety-nine international patents.
Recent Clinical Trials for Dapivirine
|Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy||National Institute of Allergy and Infectious Diseases (NIAID)||Phase 3|
|Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population||National Institute of Allergy and Infectious Diseases (NIAID)||Phase 2|
|PK Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel||Division of AIDS, US National Institute of Allergy and Infectious Diseases||Phase 1|
Top disease conditions for Dapivirine
Top clinical trial sponsors for Dapivirine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Dapivirine||See Pricing||Combination therapy intravaginal rings||International Partnership for Microbicides, Inc. (Silver Spring, MD)||See Pricing|
|Dapivirine||See Pricing||HIV inhibiting pyrimidine derivative||Janssen Pharmaceutica, Inc. (New Brunswick, NJ)||See Pricing|
|Dapivirine||See Pricing||HIV Inhibiting pyrimidine derivatives||Janssen Pharmaceutica, N.V. (Beerse, BE)||See Pricing|
|Dapivirine||See Pricing||HIV inhibiting pyrimidine derivatives||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Dapivirine||African Regional IP Organization (ARIPO)||1468||2018-03-27||See Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|